Big news for myeloma. The FDA released draft guidance supporting MRD and complete response as trial endpoints to speed accelerated approval of new treatments. This could help patients access therapies sooner. Public comments open through 3/23/26. https://mmsm.link/4pVqWA6 #IMFBSRI
New IMF research shows that acting early in smoldering myeloma may help stop cancer before it starts. Results from the GEM-CESAR study highlight how early treatment and close monitoring can protect patients and quality of life. https://mmsm.link/4boNwxd
#IMFSAB #IMFASH25 #ASH25 #IMFBSRI
New findings from our iStopMM study show that people with smoldering myeloma face higher risk of infections even at low risk. Research like this reshapes care & brings us closer to prevention. Will you support our research? https://mmsm.link/givingtuesday25
#IMFBSRI #GivingTuesday #mmsm
From 2011–2015, we expanded our global reach even further & established our signature BSRI to find the cure. We founded GMAN, supporting myeloma patient organizations, & updated the vital R-ISS staging system for myeloma. #IMF35 #IMFAMN #IMFAdvocacy #IMFBSRI #IMFGMAN #KnowMyeloma
IMF CMO Dr. Joseph Mikhael is featured in Clinical Research News! Learn about IMF's “overarching strategy as the convener of the broader myeloma community, leading to improved outcomes for patients' quality & quantity of life.” https://www.myeloma.org/node/11746 #IMFIMWG #IMFBSRI #IMFMPOWER
Should we screen for MGUS? Our iStopMM trial—the world’s largest cancer precursor screening study—aims to find out. Early intervention saves lives, but most aren’t diagnosed early. Help us fund this vital research: https://mmsm.link/4jqgiif #NCRM25 #IMFBSRI #MGUS
This #NationalCancerResearchMonth, funding research to cure and prevent #myeloma is more critical than ever. Learn how we're working to stop #MGUS from progressing to myeloma: https://mmsm.link/istopmm #UnitedByCancerResearch #NCRM25 #IMFBSRI
Should we screen for #MGUS? Our groundbreaking iStopMM study—the largest #myeloma precursor screening trial ever—aims to find out. Learn how early detection could change myeloma care, and why your support matters. Watch now: https://mmsm.link/3Yj8zKp #NCRM25 #IMFBSRI
This #NationalCancerResearchMonth, join Sylvia Dsouza, VP of Development at the International Myeloma Foundation, in supporting breakthrough studies that are driving us closer to a cure — and even prevention. Watch now: https://youtu.be/zuUavo3CIGo #UnitedByCancerResearch #NCRM25 #IMFBSRI #MGUS